Express Scripts Says Kaléo Owes $14.5M In Naloxone Rebates
By Dani Kass ( May 17, 2017, 3:23 PM EDT) -- Express Scripts Inc. on Tuesday accused Kaléo Inc. in Missouri federal court of unfairly increasing the price of its drug naloxone — which is used to save people overdosing on opioids — and then refusing to pay the pharmacy benefit manager nearly $14.5 million in corresponding rebates and fees....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.